Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 145 - 152 of 12008 results
Calling All De-Regulators: FTC Issues Request for Public Comment on Reducing Anti-Competitive Regulatory Barriers
April 15, 2025| Alert| Viewpoint
HHS Restructuring and Workforce Reductions – Key Implications for the Health Care Industry
April 14, 2025| Blog| Viewpoint
'Continuing the Trend': Mintz Tops $700M in Revenue, Sees PEP Surge 22.2%
April 14, 2025| News
Federal Energy Policy Update: A Tumultuous Start to 2025
April 14, 2025| News
OMB Issues New Guidance for the Federal Government’s Use of AI, and President Trump Signs EO for AI Data Centers — AI: The Washington Report
April 11, 2025| Article| Viewpoint
Arbitration of SEP Disputes—A Growing Trend?
April 11, 2025| Blog| Viewpoint
2025 Distinguished Service Awards
April 10, 2025| News
‘Hard to Close': PE Stalls Amid Tariff Turmoil
April 10, 2025| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|